SULT2B1 and gastric adenocarcinoma: On the basis of the data from The Cancer Genome Atlas, no statistical difference was observed in SULT2B1 mRNA expression between gastric tumor and normal gastric tissue (Fig. S2A) among tumors from patients with stomach adenocarcinoma in different stages (1–4) and grades (1–3) (Fig. S2B, C).